Computational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes

Table 3 Description of the Sample by Normal Tissue vs. PaC with and without Diabetes^a

Characteristic	Normal Tissue (n = 21)	PaC no DM (n = 37)	PaC-DM (n = 10)	p ^b
FABP-1 positive^c	1 (5%)	9 (24%)	5 (50%)	0.02
FABP-1 Score				0.02
0: Negative	20 (95%)	28 (76%)	5 (50%)
1: 1-25%	0 (0%)	7 (19%)	3 (30%)
2: 25-75%	1 (5%)	2 (5%)	1 (10%)
3: > 75%	0 (0%)	0 (0%)	1 (10%)

^aTable values are n (column %). Due to missing data on diabetes status, the total number of patients in the PaC group was n = 47. PaC-DM represent samples from patients with pancreatic adenocarcinoma and diabetes. It was not possible to differentiate new-onset diabetics from chronic diabetics.
^bp values represent Nonparametric Kruskal-Wallis ANOVA.
^cFABP-1 positive defined as FABP-1 score ≥ 1.

ISSN: 1471-230X